Industry: Pharmaceuticals & chemicals

The decision is a rare example of the General Court overruling the Board of Appeal both on procedural and substantive grounds.

02 May 2024

Limited financial resources, an uptick in trademark squatting and the growing risks of product piracy in the pharmaceutical space demand a closer look at the different resolution strategies being adopted by litigation experts across the globe.

14 March 2024

Representatives from global healthcare company Sanofi speak to WTR about their recent efforts to protect the company's NANOBODY trademark from genericism. 

05 February 2024

Featured in WTR and IAM Special Report Q4 2023: IP Disruptors 2024: The companies and people driving change and upending IP norms

25 January 2024

Featured in WTR and IAM Special Report Q4 2023: IP Disruptors 2024: The companies and people driving change and upending IP norms

25 January 2024

Featured in WTR and IAM Special Report Q4 2023: IP Disruptors 2024: The companies and people driving change and upending IP norms

25 January 2024

Featured in WTR and IAM Special Report Q4 2023: IP Disruptors 2024: The companies and people driving change and upending IP norms

25 January 2024

The court notably stressed that “dietary supplements adapted for medical or dietetic use” form a sufficiently clear category within Class 5.

22 January 2024

The results of a recent survey by the Alliance for Safe Online Pharmacies suggest that news reports and awareness campaigns about counterfeit drugs and unauthorised health providers are struggling to get through to the public.

07 December 2023

A key finding was that the word ‘kind’ is not commonly used in the pharmaceutical industry and is not descriptive of pharmaceutical products.

24 October 2023